Michelle Tigue, PHD-ABD in Filer, ID - Psychologist

Michelle Tigue, PHD-ABD is a Psychologist - Health based in Filer, Idaho. Michelle Tigue is licensed to practice in * (Not Available) (license number ) and her current practice location is 4030 Mountain Vista Ln, Filer, Idaho. She can be reached at her office (for appointments etc.) via phone at (208) 404-6049.

NPI number for Michelle Tigue is 1659023687 and her current mailing address is 4030 Mountain Vista Ln, Filer, Idaho. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1659023687.

Contact Information

	Michelle Tigue, PHD-ABD
	4030 Mountain Vista Ln, Filer, ID 83328-5555
	(208) 404-6049
	Not Available

Healthcare Provider's Profile

Full Name	Michelle Tigue
Gender	Female
Speciality	Psychologist - Health
Location	4030 Mountain Vista Ln, Filer, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1659023687
Provider Enumeration Date: 01/20/2022
Last Update Date: 01/20/2022

Medical Identifiers

Medical identifiers for Michelle Tigue such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659023687	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TH0004X	Psychologist - Health	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michelle Tigue is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michelle Tigue, PHD-ABD 4030 Mountain Vista Ln, Filer, ID 83328-5555 Ph: (208) 404-6049	Michelle Tigue, PHD-ABD 4030 Mountain Vista Ln, Filer, ID 83328-5555 Ph: (208) 404-6049

News Archive

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.

Electron-beam computed tomography - a more accurate replacement for coronary catheterizations

Electron-beam computed tomography (EBCT) is more accurate than conventional catheter angiography for detecting a dangerous congenital heart abnormality that could cause sudden death, according to research by a Saint Louis University radiologist published last month in Catheterization and Cardiovascular Interventions: Journal of the Society for Cardiovascular Angiography and Interventions.

Global Fund must resolve leadership, governance issues by end of 2012

"Good news about the Global Fund to Fight AIDS, Tuberculosis and Malaria has been sorely lacking these past few years as the organization has faced corruption allegations, financial woes, and internal reform," a Lancet editorial states.

New study evaluates use and safety of complementary medicine for children's asthma

Approximately 13 percent of parents turn to alternative therapies to treat their children's asthma, according to a new study from the Universit- de Montr-al. The findings, published recently in the Canadian Respiratory Journal, suggest that this trend is associated with a two-fold higher rate of poor asthma control in children.

Michelle Tigue, PHD-ABD - Psychologist in Filer, ID